Your account is not claimed yet. You can sign up with ORCID to claim your account.

Anna Sokolovska

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature

Nature communications

Synlogic (United States)

Purdue University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Synlogic (United States) Apr 17o 2017

United States

Principal Scientist :: Biology

Education History

Purdue University Jan 4o 2001 - Dec 21o 2005

United States

PHD :: Immunology

Publications

Liliana M Sanmarco, Joseph M Rone, Carolina Manganeli Polonio, Gonzalo Fernandez Lahore, Federico Giovannoni, Kylynne Ferrara, Cristina Gutiérrez-Vázquez, Ning Li, Anna Sokolovska, Agustin Plasencia, Camilo Faust Akl, Payal Nanda, Evelin S Heck, Zhaorong Li, Hong-Gyun Lee, Chun-Cheih Chao, Claudia M Rejano-Gordillo, Pedro H Fonseca-Castro, Tomer Illouz, Mathias Linnerbauer, Jessica E Kenison, Rocky M Barilla, Daniel Farrenkopf, Nikolas A Stevens, Gavin Piester, Elizabeth N Chung, Lucas Dailey, Vijay K Kuchroo, David L Hava, Michael A Wheeler, Andrew T Chan, Roni Nowarski, Eduardo Balsa, Jose M Lora, Francisco J Quintana
Lactate limits CNS autoimmunity by stabilizing HIF-1α in dendritic cells. Nature (2023)
Jason John Luke, Sarina A Piha-Paul, Theresa M Medina, Claire F Verschraegen, Mary Varterasian, Aoife M Brennan, Richard J Riese, Anna Sokolovska, James F Strauss, David L Hava, Filip Janku
Phase I study of SYNB1891, an engineered E coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jason John Luke, Sarina A Piha-Paul, Theresa M Medina, Claire F Verschraegen, Mary Varterasian, Aoife M Brennan, Richard J Riese, Anna Sokolovska, James F Strauss, David L Hava, Filip Janku
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Daniel S Leventhal, Anna Sokolovska, Ning Li, Christopher Plescia, Starsha A Kolodziej, Carey W Gallant, Rudy Christmas, Jian-Rong Gao, Michael J James, Andres Abin-Fuentes, Munira Momin, Christopher Bergeron, Adam Fisher, Paul F Miller, Kip A West, Jose M Lora
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity. Nature communications 11 (1) (2020)

Anna Sokolovska.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anna Sokolovska